Zubir Ahmed MP: speeches

Speeches

• 10 Jun 2026 · Glasgow Commonwealth Games 2026 · Hansard source

  More

  It is a pleasure to serve under your chairship, Mr Twigg. It is also an honour to have the Under-Secretary of State for Culture, Media and Sport, my hon. Friend the Member for Barnsley South (Stephanie Peacock), respond to this debate. She knows Glasgow well and was generous with her time when she was last in the city, visiting Crookston castle, the Nethercraigs sports complex—which is not a Commonwealth games venue, unfortunately, but perhaps next time—and the Pakistani Street Food café. I believe that she is due in Glasgow South West tomorrow, so it is wonderful that she is responding to the debate. As well as congratulating my hon. Friend the Member for Glasgow West (Patricia Ferguson) on securing the debate, it is important to thank her, as other Members have done, for her long record championing Glasgow and sport. As the Minister for Tourism, Culture and Sport in the Scottish Labour Government, she helped to lay the important foundations of what we celebrate today—the ambition, the infrastructure and the belief that Glasgow could stand on the world stage and deliver, all of which was seeded during her tenure as a Minister. The 2014 Commonwealth games showed what Glasgow was capable of. Under a Labour council that understood what sport could do, and what it could unleash for communities, the city welcomed athletes and visitors from across the globe, and by wide consensus, it did not disappoint. The legacy of those games was lasting, not only in the venues and infrastructure but in the civic pride felt by the volunteers and citizens, and by the young people who watched those games and dared to dream to become athletes themselves. In that sense, Glasgow 2026 does not start from scratch; it stands on the shoulders of giants like my hon. Friend the Member for Glasgow West—that is a very special thing indeed. These games are also personal to me and my own Commonwealth story. In 1963, my father came to this country by road from Pakistan, a proud Commonwealth nation. I grew up in the city and was trained as a surgeon by many Commonwealth citizens. I now have the singular honour of being the Member of Parliament for Glasgow South West, perhaps the most diverse constituency in Scotland, and one that has been shaped by its many Commonwealth connections from Pakistan, India, Bangladesh and the Caribbean. I am confident that when the athletes from the 74 nations touch down in Glasgow later this year, they will feel at home, with smells and languages quite familiar to them, thanks to the diverse communities that occupy Glasgow. I hope that, in some sense, they will feel at home during their time here, as one Commonwealth family bound by the shared values, histories and stories that we all carry. It is particularly important to emphasise those shared values today, because last night we saw some violence on Buchanan Street in Glasgow, under the watchful eye of the statue of Donald Dewar, the father of our nation. That underlines that Glasgow is not immune to the challenges of social cohesion—or, indeed, prejudice. It is therefore timely to remind ourselves that, as a Commonwealth family, those shared values must come to the fore, and we as Members of this place all have a responsibility to articulate those values in these times of stress and turbulence. When telling the story of the 2026 Commonwealth games and how they came to Glasgow, it is important to re-emphasise that when Victoria withdrew, the games were in danger of fizzling out. In fact, there was even a danger that Commonwealth games as a concept could come to an end. However, Glasgow, the UK Government and the Department for Culture, Media and Sport stepped forward to ensure that the games can once again be celebrated, and that our Commonwealth family can celebrate, too. Finally, the King’s baton, with which the games will be opened, was handcrafted by GalGael, a social enterprise based in Govan in Glasgow South West, using reclaimed wood from Pollok Country Park. I do not think there is a better symbol of Glasgow than Glasgow timber being handcrafted by Glaswegians and travelling to every part of our Commonwealth ahead of these games. Glasgow has earned this moment, and I am confident that it will make the most of it.

• 10 Jun 2026 · Glasgow Commonwealth Games 2026 · Hansard source

  More

  To develop the point made by my dear hon. Friend the Member for Glasgow East (John Grady), I have been worshipping at Glasgow central mosque since it opened in 1984, and it is timely to remind hon. Members that the mosque was at the epicentre of the last Commonwealth games in Glasgow. As hon. Members will appreciate, a number of athletes were coming from Muslim-majority Commonwealth countries, and it was Ramadan at the time. The mosque became an epicentre for many athletes; it was where they first and foremost found the community of Glasgow. I am also shocked to hear that last night the mosque had to be closed, but I am deeply confident that, in the course of the games, the people of Glasgow will show themselves to be the welcoming, diverse community that they have always been and always will be. Does the Minister agree that the people do make Glasgow?

• 21 Apr 2026 · Wheelchair Provision: Independent Review Body · Hansard source

  More

  Ultimately, ICBs are responsible for delivering the framework. The Government are held accountable in the manner being seen today, and I have no doubt that in the new structures that we propose there will be further accountability, because in many ways the middleman will be removed and we will have more direct oversight as to what is going on with wheelchair services and other services up and down the country. I take the hon. Member’s point on data as well. I am the Minister responsible for data, health innovation and innovation in general, and I think this moment of restructuring, whether in relation to wheelchair services or other parts of the system, is a moment for us to really get into the 21st century with our capabilities for monitoring data for operational and capacity planning. I am very happy to share with him some of my thoughts about that over a cup of tea later, if he is interested. The community health services situation report will be used to monitor ICB performance against waiting time targets in 2026-27. Those targets will guide systems to reduce the longest waits. In addition, the 10-year plan makes a commitment to reviewing the complaints regulations, and NHSE and the Department of Health and Social Care are developing plans to achieve that. NHS England has developed policy, guidance and legislation to support ICBs to reduce delays and unacceptable regional variation in the quality and provision of wheelchair services. In April 2025 NHS England published the wheelchair quality framework, in collaboration with the wheelchair advisory group, which I understand includes the Wheelchair Alliance and Whizz Kidz, both of which were recognised by hon. Members in the debate today. That framework is designed to assist ICBs and NHS wheelchair service providers in delivering high-quality provision that offers improved access, outcomes and experiences. The framework sets out quality standards relevant to all suppliers and aligns with the Care Quality Commission assessment framework that applies to providers, local authorities and integrated care systems. Those quality standards should be used to develop local service specifications and to benchmark current commissioning and provision. Other measures taken by NHS England include the establishment of a national dataset on wheelchair waiting times to increase transparency and to enable targeted action if improvement is required, and the introduction of the legal right to a personal wheelchair budget in 2019. Personal wheelchair budgets provide a clear framework for ICBs to commission personalised wheelchair services that are outcomes-focused and integrated with other aspects of care.

• 21 Apr 2026 · Wheelchair Provision: Independent Review Body · Hansard source

  More

  It is a pleasure to serve under your chairmanship, Dr Murrison. I congratulate my hon. Friend the Member for Bexleyheath and Crayford (Daniel Francis) on securing this important debate and also on challenging us, born of his lived experience, to make the lives of disabled people better and better lived across our country. We are grateful for his presence in this House and this place, every single day. I am also grateful to my hon. Friend for the work he has done to champion this interest more generally in his capacity as co-chair of the all-party parliamentary group for wheelchair users. In recent months wheelchair services have received considerable attention, both within Parliament and more widely. As has been highlighted, last month I participated in a debate on the provision of disability equipment, brought forward by the hon. Member for Aberdeenshire North and Moray East (Seamus Logan). I have been struck by the compelling testimonies shared during those discussions and the ones today, highlighting the profound impact that timely access to appropriate disability equipment can have on people’s lives. This is a matter clearly deserving of much more attention. Since the previous debate on this topic, I have written to the national quality board to request that disabled people and the equipment they use are considered as part of the board’s ongoing work to improve quality and reduce inequality across health and care services. I am pleased to update that the board has confirmed it will take this forward. This Government remain steadfast in their commitment to ensuring that disabled people can access the services and support they need. Through our reforms to health and social care, we are dedicated to delivering meaningful change that will make that vision a reality. Integrated care boards, as has been highlighted, are responsible for commissioning local wheelchair services. Responsibility for providing disability equipment lies with local authorities or the NHS, depending on the person’s needs. For adults and children with long-term complex needs, services are typically provided by NHS wheelchair services. There is a range of NHS wheelchair providers across England, as we have heard. I acknowledge the concerns that the hon. Member for Hinckley and Bosworth (Dr Evans) raises about NRS. My hon. Friend the Minister for Care and I will be having discussions about that, and it would be appropriate to write the hon. Member an urgent letter to update him, as I know that he is genuinely concerned about the topic. ICBs are expected to monitor service provision and effectively manage contracts with their commissioned providers. Although the latest data from NHS England shows a reduction in wheelchair waiting times for adults, I recognise that far too many people of all ages, as we have heard today, experience unacceptable delays for appropriate equipment. The covid pandemic had a significant impact on wheelchair services, from which we are still suffering in terms of supply chain disruption. That has meant that waiting times for both adults and children have fluctuated unnecessarily—well, unacceptably—as services have worked to recover. Those with more complex needs can also experience delays due to the lead-in time for supply of more bespoke equipment. I understand that there have been complaints about the quality of services commissioned by some ICBs. Some of these are being dealt with on an individual basis by the Parliamentary and Health Service Ombudsman, following escalation by individual patients. As part of its oversight of ICBs, NHS England is also gathering intelligence through regional teams to understand fully the issues being raised. It is important that local commissioners have the discretion to decide how best to meet the needs of their local population, and we are giving systems control and flexibility over how that is done. None the less, the Government are taking action to support local systems in delivering effective wheelchair services. Although there are no plans at the moment to establish a national review body to oversee wheelchair provision, the medium-term planning framework, published in October, requires that from this year all ICBs and community health services should actively manage and reduce waits over 18 weeks and develop a plan to eliminate all 52-week waits. The framework also states that in 2026-27, ICBs are required to “increase community health service capacity”— including wheelchair services— “to meet growth in demand, expected to be approximately 3% nationally per year”.

• 15 Apr 2026 · Draft Health and Social Care Act 2008 (Regulated Activities) (Amendment) Regulations 2026 · Hansard source

  More

  I beg to move, That the Committee has considered the draft Health and Social Care Act 2008 (Regulated Activities) (Amendment) Regulations 2026. It is a pleasure to serve under your chairmanship, Mr Stringer. This statutory instrument makes an important change. It will amend the Health and Social Care Act 2008 (Regulated Activities) Regulations 2014 so that the treatment of disease, disorder or injury—TDDI—is brought within the regulatory scope of the Care Quality Commission. The change will be for TDDI provided in sports grounds and gymnasiums or under temporary arrangements at sporting or cultural events where it is delivered for the benefit of those taking part in or attending those activities. Members will recall the tragic events of 22 May 2017, when the Manchester Arena bombing killed 22 people and injured more than 1,000. The subsequent Manchester Arena inquiry uncovered serious failings, including inadequacies in the provision of healthcare services at the arena. The inquiry noted that those shortcomings may have been present in other venues across the country, in part because of the absence of regulation. A central finding of the inquiry was clear: the Department of Health and Social Care should consider changes to the law to enable the CQC to regulate healthcare delivered at events. The CQC has outlined initial concerns about the quality of care provided at events. It has heard serious allegations where unregulated provision has resulted in harm. The Government are committed to acting on the inquiry’s recommendations and strengthening public safety. I recognise that these changes are overdue, but it was important to consider the impacts carefully, and I am pleased that they have now been laid. This statutory instrument brings TDDI at events into line with hospitals, clinics, ambulances, GP surgeries, community services and care homes, where it is already regulated. That means that a provider delivering TDDI at an event must register with the CQC and comply with the same robust regulatory standards that apply elsewhere in our healthcare system. Some of these providers will already be registered to provide TDDI in other settings, and the process will be quicker for them. There has been some confusion about what TDDI actually is. It includes a wide range of treatments from emergency interventions to ongoing care for long-term conditions. I wish to be clear to Members that TDDI does not include first aid. First aid remains outside the scope of CQC regulation. To support providers to make this transition, they will have significant time to prepare. I can assure everyone involved that there will be a 15-month period in which providers can register and the CQC can process registrations before regulation becomes enforceable. The CQC will consult on guidance and produce supporting materials to help determine whether registration is required. The provision to allow registration will come into force on 7 September 2026. It will not become an offence to provide TDDI as an unregulated provider until 6 December 2027. In developing this policy, the Government have considered a range of options carefully, guided by the Manchester Arena inquiry findings. We concluded that partial removal would risk fragmenting provision, and a threshold based on event size would not reflect risk.

• 14 Apr 2026 · National Suicide Prevention Standard · Hansard source

  More

  My hon. Friend is always knowledgeable about these matters and she tempts me to egress across the confines of my departmental portfolio. I am happy to cite her recommendations in my correspondence with colleagues in the Department for Business and Trade when I try and set up a meeting for my hon. Friend the Member for Blaydon and Consett. The role of employers generally cannot be understated. As the suicide prevention strategy clearly sets out, by improving support practices and conversations employers can and do save lives from suicide. Almost three quarters of people who take their own lives are not in contact with NHS mental health services. That points to the importance of public and private sector organisations—well beyond the confines of what we see as the traditional NHS—that are well placed to reach those vulnerable people most at risk. Workplaces provide the perfect opportunity to signpost people to the support they need. Employers should support practices and conversations that help to prevent suicides—for example, by having employment assistance programmes, line manager training and support networks in place for employees. Every employee should feel supported, and every employer should ensure that support is known of and available to their staff. As has been highlighted, we know that some sectors are disproportionately affected by suicide. For example, suicide rates in construction are four times higher than in other business sectors. The Construction Leadership Council’s mental health project has focused, through the lens of prevention, on identifying the primary root mental health causes impacting construction workers. The project, in partnership with Mates in Mind and the University of Warwick, held a series of regional focus groups with on-the-ground workers and identified those causes as including late payments, a lack of stable work, and workers having to travel and stay far away from family and loved ones. The Department for Business and Trade consulted on those issues and received around 3,000 responses. An action plan, together with a joint code of practice setting out how employers across the sector can provide a more supportive environment to address and prevent those issues specifically, will be published this summer. With suicide prevention, we often talk about the importance of meeting people where they are. Ensuring that people are supported by their workplaces is one valuable way of doing that, and the Government are committed to finding more opportunities to ensure that every person requiring support can access it readily. For example, my counterpart Baroness Merron, alongside co-chairs Money and Mental Health, convened senior stakeholders from financial services to discuss the role they could play in supporting people at risk—both their customers and their employees. I understand there was a great appetite in the room to take further action on this matter, and Baroness Merron is working closely with officials to progress this work at pace. I encourage all workplaces and employers to familiarise themselves, and align their work practices, with the Government’s suicide prevention strategy and to consider how they can best support their staff. I would also encourage them to consider drawing on the BSI standards as an exemplar tool to help embed suicide prevention in working practices. Finally, as the BSI standard highlights, the importance of community, both inside and outside the workplace, cannot be overstated. That is why so many of the Government’s ambitions surrounding suicide prevention, and indeed wider prevention, hold community at their core. With our 10-year health plan, we are shifting care and support from traditional institutions into the community, and our focus is more firmly on prevention. Through the new community-based mental health centres that are being piloted, people and families can receive care and treatment when they need it, in their community, 24 hours a day, and in a much calmer environment than one finds in traditional A&E departments.

• 14 Apr 2026 · National Suicide Prevention Standard · Hansard source

  More

  My hon. Friend is trying to steal the conclusion of my speech, so I will bring it forward. I am always delighted to meet her, and she knows I am happy to contribute to any roundtable that she feels needs my attendance. I can charge my officials with the task of getting that organised. Those community-based mental health centres are co-delivered with primary care specialist services that can be drawn on as required. People can receive psychological therapies, medication and other interventions, while also having access to expertise that can help with wider issues that may be impacting on their wellbeing and recovery, such as issues with housing, employment and peer support. Our suicide prevention support pathfinder programme for middle-aged men will invest up to £3.6 million over three years in areas of England where middle-aged men face the greatest risk of suicide. It will support new ways of embedding effective, tailored support for middle-aged men within their communities and will create clearer, more joined-up pathways into existing local suicide prevention systems. Today’s discussion has without doubt highlighted that suicide prevention truly is everybody’s business. Every person, organisation and service has a role to play. We can all do more to ensure that we are equipped with the skills that can and will save lives. Our suicide prevention strategy sets out a comprehensive, evidence-driven plan to reduce the number of lives lost to suicide across our country. It highlights the important role that employers and organisations can and should play in supporting their staff to get the support they need. Guidance such as the BSI’s “Suicide and the Workplace” standard brings welcome visibility to just how important that role is. I extend my thanks to everyone who contributed to and was involved in the development of the standard. In conclusion, I know how personally painful debates such as this can be, but all hon. Members will know that the impact of these discussions goes well beyond the four walls of our Parliament and into the streets. That awareness is so important, and I am grateful to my hon. Friend the Member for Blaydon and Consett for securing this debate. I would be delighted to meet her and to organise the meetings I outlined. Question put and agreed to.

• 14 Apr 2026 · Topical Questions · Hansard source

  More

  I commend the community groups in the hon. Gentleman’s constituency. He will know that there are record amounts of funding going into mental health provision under this Government. We are committed to ensuring that that funding is disseminated into the community, by moving more services from hospitals into the community.

• 11 Mar 2026 · Disability Equipment Provision · Hansard source

  More

  I am very grateful to my hon. Friend. He always channels personal experience in such a productive way and he is a credit to this House in the way he conducts himself. I remember his maiden speech with great fondness in that regard. I do agree, and I will come later in my speech to how we can maintain quality more persistently across the whole system. Access to temporary wheelchair provision to support hospital discharge is also determined locally by ICBs. We recognise that elements of the NHS—despite it being on the road to recovery—are functioning below par and that many people are waiting too long to access equipment such as wheelchairs. During the pandemic, some wheelchair services experienced lower referral rates, which led to a surge in referrals post pandemic. Because of that, providers not only reduced their services but now, of course, face a backlog of referrals. That has meant unacceptable waiting times for both adults and—sadly—children, and those have fluctuated as services work to recover. However, action is being taken to address waiting times in England. In October 2025, we published the NHS medium-term planning framework, requiring all ICBs and community health services to actively manage and reduce waits above 18 weeks and to develop a plan to eliminate all 52-week waits. The community health services situation report will be used to monitor ICB performance against waiting-time targets in 2026-27, and it currently monitors waiting times for children, young people and adults under “Wheelchair, orthotics, prosthetics and equipment”. These targets will guide the system to reduce the longest waits first.

• 11 Mar 2026 · Disability Equipment Provision · Hansard source

  More

  Mr Betts, it is a pleasure to serve under your chairmanship. I start by thanking the hon. Member for Aberdeenshire North and Moray East (Seamus Logan) for securing the debate, as well as all Members who contributed. We, of course, want disabled people to access and experience healthcare services on an equitable footing and to have a healthcare service that is responsive to their needs. That includes making sure that they have the right equipment at the right time to maintain independence for as long as possible, whether that means wheelchairs, mobility aids or other assistive technologies. We recognise the profound impact that delays in receiving disability equipment have on people’s quality of life, and I will set out the action that the Government are taking. Before I do so, however, I want to take a moment to acknowledge the points raised by the hon. Members for Tiverton and Minehead (Rachel Gilmour) and for Mid Sussex (Alison Bennett), particularly the cases they raised. I will certainly ensure that I take a personal interest in the case described by the hon. Member for Tiverton and Minehead and that the relevant DWP Minister also has an opportunity to address that particularly harrowing case. The Liberal Democrat Front Bencher, the hon. Member for Epsom and Ewell (Helen Maguire), asked for an update on the Design for Life statistics on recycling and reusing, and I will get my officials to get back to her on that. We are committed to ensuring that disabled people have access to the services and support that they need. The Opposition spokesperson, the hon. Member for Hinckley and Bosworth (Dr Evans), asked about our NHS reforms and whether that might be an opportunity to think about better end-to-end commissioning and strategising on the topic. I can assure him that those conversations are being had both in the context of disability and, with regard to special educational needs and disabilities, in the Department for Education. There are a number of topics that, if we are honest with ourselves, have been often neglected in the last couple of decades and have a material impact on the quality of life for disabled people, sometimes for want of very simple changes to practice and, potentially, legislation, so I am very happy to take that on board with the Bill team. The reforms that we are taking forward in the health and social care space will hopefully help us to achieve what I have outlined. The 10-year health plan specifically identifies disabled people as a priority group for the development of neighbourhood healthcare, offering more holistic and ongoing support. We are making £4.6 billion of additional funding available for adult social care in 2028-29, compared with ’25-26, to support the sector in making some of those improvements. In July ’25, the Government announced that they would develop a new plan for disability, setting out a clear vision to break down barriers to opportunity for disabled people. That of course aligns with every Department having a Minister responsible for disability. We meet regularly to discuss challenges, particularly some of the ones highlighted during this debate, which often do not fit neatly into one Department’s purview. As hon. Members will be aware, health and social care are largely devolved across the UK. I will talk mainly about England, but of course I am the representative of a Scottish constituency, like the hon. Member who opened the debate, and he will understand if I just mention that we are committed, through the Barnett formula, to funding the NHS in Scotland, as we are doing in England; there is a £9.1 billion real-terms uplift in the Scottish budget over the period of the spending review. In England, integrated care boards are responsible for commissioning services to meet the health needs of their local population, and responsibility for providing community equipment to disabled people typically falls at the moment, as has been outlined, to local authorities. They have a statutory duty to make arrangements for the provision of community equipment to disabled people in their area. That equipment can be free for the recipient if the person is assessed as having eligible needs. Types of support include equipment to enable people to live more independently, such as grab rails, walking aids and wheelchairs for short-term use. Responsibility for managing the market for these services rests with local authorities. For people with long-term, complex mobility needs, support is provided by the national health service, based on assessed need. That may involve the provision of specialist equipment adapted to the specific needs of the individual, and can include both powered and manual wheelchairs.

• 11 Mar 2026 · Disability Equipment Provision · Hansard source

  More

  Well, I have not got time. I will write more fully regarding his correspondence. I am genuinely disappointed, if it is true, that he has not been responded to since September. In addition, the 10-year plan makes a commitment to reviewing the complaints regulations. NHS England and the Department are developing those together to achieve better accountability. The Government are also taking wider action to support disabled people through the 10-year health plan. On neighbourhood health, the neighbourhood health service will support disabled people to have choice and control over their care. That includes increasing the uptake of personal health budgets, which provide individuals with that greater choice and control over how their health is assessed and their wellbeing needs are met. One aim is to have a neighbourhood health centre in each community, bringing the NHS, local authority and voluntary sectors together to create a holistic offer that meets people’s needs in the place that they are. We expect these services to be designed in a way that reflects the specific needs of disabled people, with a focus on personalised, co-ordinated care. I particularly think that this is an opportunity, as we move care from hospital to the community, to address some of the concerns raised in the debate today. On social care, the Government are also driving forward improvements for disabled people. We are enabling people to have more choice and control over their care—through greater use of direct payments, for example. We are also expanding care options to boost independent living at home and have recently confirmed £723 million for the disabled facilities grant in 2026-27. The total DFG budget across 2025-26 and 2026-27 is £150 million more than the total budget across the previous two years. That represents an 11% increase and will support more disabled people to get the vital home adaptations that they might need. The Better Care Fund, which took effect in April 2025, is a framework for ICBs and local authorities to make joint plans and pool budgets to deliver better joined-up care. That can include the provision of assistive technology and equipment, such as wheelchairs. This financial year, ICBs and local authorities plan to spend £440 million on assistive technology and equipment, and we have introduced care technology standards to help them to choose the right support. In addition, as we move from hospital to community, commissioners can, if they wish, think about better co-commissioning, transcending traditional boundaries between local authorities, social care and the NHS. I am grateful to the hon. Member for Aberdeenshire North and Moray East for securing this important debate and I want to respond to a question he asked. Whether we call it a strategy or a framework, there is a real opportunity at this time of change in the NHS—including the development of a national quality board at NHS England, which will come into the Department of Health and Social Care once NHS England is abolished —to genuinely think about how we define “quality” for disabled people and about the equipment and the spaces that they use. Again, I will be very happy to discuss that with my colleagues in charge of the quality board. I will write to the hon. Gentleman with specifics that we can perhaps tease out after this debate today. We recognise the life-changing impact that having timely access to suitable disability equipment can have on the lives of disabled people across the United Kingdom, in every nation. The Government are dedicated to ensuring that all disabled people have access to the services and support that they need to live a fulfilling life; the presence of disability Ministers in each Department is certainly progress in that regard. Our work to reform health and social care, alongside the new plan for disability, will also help us to achieve that.

• 11 Mar 2026 · Disability Equipment Provision · Hansard source

  More

  I am grateful to the right hon. Gentleman, and to those who raised this matter earlier in the debate. It does trouble me deeply that we have a situation in which equipment is going unused when there is that need in another part of the system. I actually feel that quite acutely. Hon. Members may know that I am a vascular surgeon; at times, unfortunately, some of my job involves having to amputate people’s limbs for end-stage vascular disease. I see for myself that transition from someone being able-bodied to needing assistance, and, where that assistance is not available, the impact that has, especially when people know there is this lack of productive exchange of equipment in the system highlighted by hon. Members today. I am therefore very happy to take the issue forward with my officials to see what can be done further to marry the demand and the supply together in the country. Regarding wheelchair provision, NHS England has developed policy guidance and legislation to support ICBs to commission effective, efficient and personalised wheelchair services. I again nod to the remarks from the hon. Member for Aberdeenshire North and Moray East on making sure we get better, more efficient and personalised service provision. In April 2025, NHS England published the wheelchair quality framework, developed in collaboration with the NHS England national wheelchair advisory group. The framework is designed to assist ICBs and NHS wheelchair service providers in delivering high-quality provision that offers improved access, outcomes and experience. NHS England introduced personal wheelchair budgets, including legal rights, in 2019, providing a clear framework for ICBs to commission personalised wheelchair services that are outcomes-focused and integrated. Those budgets give people greater choice over the wheelchairs that they are provided with. Additionally, the model service specification for wheelchairs sets out that wheelchair assessments should take place in the most suitable environment based on the needs of that individual. NHS England is aware, as am I, that several complaints have been made about the quality of services commissioned by some ICBs. NHS England is working through the appropriate regional teams to gain intelligence from those ICBs on quality concerns and contracting arrangements, to fully understand the issues being raised.

• 3 Mar 2026 · Draft Human Medicines (Amendment) Regulations 2026 · Hansard source

  More

  I beg to move, That the Committee has considered the draft Human Medicines (Amendment) Regulations 2026. It is a pleasure to serve under your chairmanship, Mrs Harris. In response to the covid-19 pandemic, multiple temporary amendments were made to the Human Medicines Regulations 2012 in autumn 2020 to enable the roll-out of the covid-19 and influenza vaccination programmes. Those amendments were extended in 2022 and 2024 following public consultation, and are due to lapse on 1 April 2026. This instrument will retain several provisions within those regulations as permanent legislation and expand them to other vaccines. It is designed to build on the benefits that the amendments have provided to date, as well as the wider lessons learned during the pandemic and in recent polio and measles, mumps and rubella vaccine catch-up programmes. It will support the safe supply, distribution and administration of a wider group of vaccines, helping the ongoing development of a vaccination system that is fit for the future. I will briefly set out what each of the regulations does. Paragraphs (1) and (2) of regulation 3A enable trained healthcare professionals, or staff under the supervision of trained healthcare professionals, to conduct the final stage of assembly and preparation of covid-19 vaccines, without additional marketing authorisations or a manufacturer’s licence being required. That enabled the bulk assembly of covid-19 vaccines during the pandemic. Given the more targeted approach of recent covid-19 vaccination campaigns, this instrument allows the provisions in paragraphs (1) and (2) of regulation 3A to lapse from 1 April this year. Paragraphs (3) and (4) of regulation 3A permit holders of a wholesale dealer’s licence who do not hold a manufacturer’s licence to re-label covid-19 vaccines to reflect changes in shelf life resulting from product thawing. This instrument retains those provisions as permanent legislation, and expands them to include any vaccine against any infectious disease. That will enable a more efficient use of the capable vaccinator workforce, and will support further flexibilities in our supply chain. Regulation 19 allows covid-19 and influenza vaccines to be moved between different NHS service providers at the end of the supply chain, without the need for a wholesale dealer’s licence. This instrument retains those provisions as permanent legislation, and expands them to include any vaccine against any infectious disease, with relevant safeguards to regulate its use. That will ensure that vaccines can be rapidly deployed in exceptional circumstances in response to public health needs. Regulation 247A enables the use of an extended workforce who are legally and safely able to administer covid-19 or influenza vaccines without the input of a prescriber, using an approved protocol. This instrument allows regulation 247A to lapse from 1 April 2026, and introduces a new, permanent provision—regulation 235A —to continue the use of an extended vaccinator workforce through the introduction of a vaccine group direction. That will support the use of an extended workforce to administer any vaccine against any infectious disease where directed by a national body, and will ensure that the UK has the necessary agility and flexibility in its workforce to deliver those vaccinations. Regulation 233 enables persons lawfully conducting a retail pharmacy business to deliver covid-19 and influenza vaccination services off their registered premises, under a patient group direction. This instrument expands that provision to include any vaccine against an infectious disease. Additionally, to enable those services to continue after paragraphs (1) and (2) of regulation 3 lapse from 1 April this year, this instrument amends regulation 3 to enable pharmacists to prepare or assemble medicines for a patient in the course of their treatment without a manufacturer’s licence. That will ensure that community pharmacies can deliver vaccination services off their registered premises, enabling them to deliver targeted outreach programmes. Schedule 17 introduced a category of occupational health vaccinators, who are permitted under the written directions of a doctor to administer covid-19 and influenza vaccines as part of an NHS or local authority occupational health scheme. This instrument amends the list of professionals able to deliver OHS vaccinations, aligning it with the professionals able to supply medicines under a patient group direction. In addition, it expands the scope of schedule 17 to cover any vaccination or immunisation offered as part of an OHS. Those changes will improve access to vaccines for staff within and beyond the health and social care sector, protecting them in the vital roles that they do. In developing this statutory instrument, from 5 September to 28 November 2025, the Government conducted a public consultation on our proposals, hosted by the Department of Health and Social Care for England, Wales and Scotland, and jointly with the Department of Health for Northern Ireland, as medicines regulation is a transferred matter in Northern Ireland, and a reserved matter in Scotland and Wales. The consultation received 218 responses, from organisations and individuals sharing professional and personal views, the majority of which were supportive of the proposals. We received many positive comments about how the flexibilities within the regulations have helped to increase access and efficiency across the system, while effectively utilising the workforce that came into place to deliver covid-19 and influenza vaccinations following the covid-19 pandemic. The consultation posed 15 questions on the technical aspects of the regulations, and we saw broad agreement on each of those proposals. Given the technical nature of the questions and the limited time the Committee has to discuss this instrument, I will not provide an immediate analysis of each response here; however, the published Government response can be accessed on the gov.uk website. This instrument builds on the successes of the large-scale vaccination programmes during the covid-19 pandemic to support patient safety, improve access to and availability of vaccines, and ensure that the vaccine system continues to innovate. The changes will implement improvements that will help to facilitate the shift from “sickness to prevention”, as described in the Government’s 10-year health plan, helping to restore trust in vaccinations and ultimately increasing vaccine uptake. Regulations 3 and 8 will enable community pharmacies to play a bigger role in prevention by expanding their role in vaccine delivery and enabling targeted outreach in areas where health inequalities remain pervasive, and where evidence indicates that doing so is clinically appropriate and value for money. The changes will support the delivery of commitments on vaccination and immunisation frameworks in Scotland and Wales, and an instrument will be laid in the Northern Ireland Assembly in parallel to these regulations, to deliver changes to the vaccination system across the United Kingdom. To conclude, the instrument makes changes that will permanently support the safe supply, distribution and administration of a wider range of vaccines, and the proposals were supported by the majority of respondents to our consultation. I therefore commend the regulations to the Committee, and hope that hon. Members will support them.

• 3 Mar 2026 · Draft Human Medicines (Amendment) Regulations 2026 · Hansard source

  More

  I am not clear on why they have been removed from the list. However, I certainly expect that anyone who is reasonably trained will be able to deliver vaccines in the settings that we have proposed, which include community hospitals and everywhere in between, when we need to think about hard-to-reach communities. The shadow Minister also asked a question on vaccine group direction versus patient group direction. The primary difference is that the VGD allows for the separation of the decisions to treat and provide consent by a registered healthcare professional, which still need to exist, from the administration of the vaccine, which is then done by a separate individual. That is not possible under a PGD, so it is about separating the roles. However, I reassure her that the consent process in prescriptions is paramount, and she is right that it must continue to be if we want to invite people’s confidence in the vaccination process.

• 26 Feb 2026 · Eating Disorders Awareness Week · Hansard source

  More

  My hon. Friend is absolutely right. Being proactive and following the evidence should be our north star when we are formulating policy; I know that is true of my right hon. Friend the Secretary of State for Science, Innovation and Technology. The Royal College of Psychiatrists has been explicit about eating disorders and end-of-life care. Anorexia nervosa is not a terminal illness in its own right. The college’s guidance on medical emergencies in eating disorders was developed precisely to ensure that preventable deaths become a thing of the past. NHS England is clear that no patient with an eating disorder should routinely be placed in palliative care. Our focus must always be on treatment and recovery, and underpinned by the hope of recovery. We also share concerns about the accurate recordings of deaths where eating disorders may have been a contributing factor. The hon. Member for Bath outlined some of her frustrations regarding correspondence with the Ministry of Justice and I would be happy to take up that call on her behalf to make sure that she gets the correspondence that she is entitled to. The statutory medical examiner and coroner system provides a clear framework to ensure that deaths are properly investigated and recorded so that lessons are identified and patient safety is strengthened. Although it is for the coroner to exercise independent judicial discretion to determine what is recorded as the medical cause of death, I can reassure hon. Members that the coroner’s office has been undergoing training to ensure that the recording of deaths associated with eating disorders is done more accurately and proactively. Accurate recording matters, and we will continue to work with our partners, including colleagues in the Ministry of Justice and clinicians, to ensure that not only are the statistics captured, but the learning underpinning those statistics is reflected in genuine improvements to care. Eating disorders are serious and complex mental illnesses that can affect anyone at any age and in any community or family. They require timely treatment, skilled professionals and sustained support thereafter.

• 26 Feb 2026 · Eating Disorders Awareness Week · Hansard source

  More

  I can certainly commit to the hon. Lady that mental health spending in real terms will go up every single year. It went up by £688 million in real terms this year. [ Official Report, 16 March 2026; Vol. 782, c. 6WC.] (Correction) The good nature of this debate permits me to push back only gently against the hon. Member for Sleaford and North Hykeham, who talked about spending in the NHS, but I do feel I need to push back a little: one of the reasons why that percentage in statistical terms is lower, but the spend in real terms is higher is because we had to spend so much more money—the record £26 billion that was afforded in additional spend by the Chancellor in the Budget—in other parts of the health service to compensate for the decay and decline in the NHS over the last 14 years. But the hon. Member for North Shropshire (Helen Morgan) has my commitment to the overall philosophy that mental health spending will increase year on year. As I was saying, eating disorders are serious and complex; over and above skilled professionals, they also require compassion, understanding and collective responsibility. Through the 10-year health plan, we are shifting care closer to home; strengthening early intervention; expanding the workforce where necessary, such as with community mental health workers; improving standards and investing in the community services that make recovery possible. We are also equipping staff with the right training, protecting young people online—while continuing to improve and explore the mechanisms through which we can do that—and working with experts and those with lived experience to ensure that the reform we are choosing to pursue delivers real and lasting change. We know that the policy framework alone is never enough. Change also depends on the voices of campaigners, including many who join us here today, clinicians, families and those who have shared their lived experience. I can assure everyone that their advocacy continues to shape this Government’s approach, and it will continue to do so. To those living with an eating disorder, and to the families supporting them, I want to say this: “You are not invisible. You are not alone.” This Government are committed to building a system that responds with urgency, expertise and compassion. Our task—across this House and beyond it—is to ensure that when someone reaches out for help, the system we create is ready to respond with urgency, expertise and, crucially, hope. I once again thank hon. Members for contributing to this debate and I look forward to continuing this work with colleagues from across the House.

• 26 Feb 2026 · Eating Disorders Awareness Week · Hansard source

  More

  It is an honour and a pleasure to serve under your chairmanship, Ms Vaz. I congratulate the hon. Member for Bath (Wera Hobhouse) on securing today’s debate and raising this important topic—as she always does. I also pay tribute to her for her long-standing advocacy on this topic and for all the work she does in the eating disorders all-party parliamentary group. She is joined today by a number of hon. Members from across the House, who have made thoughtful contributions. One hon. Member who is conspicuous by his absence—he has already been mentioned, and I informed him in advance that I would mention him too, Ms Vaz—is my hon. Friend the Member for Isle of Wight West (Mr Quigley). He is my friend, and he is conspicuous because of the tireless work he does and the way he advocates for persons with eating disorders. I know that that is born out of personal interest and pain. We miss his presence here today and send him our good wishes from across the House. It is important that we are having this debate today to note Eating Disorders Awareness Week. This year’s theme rightly places the focus on the power of community, which speaks to a simple but profound truth: no one should face an eating disorder alone. Recovery is not only about clinical treatment, vital though that is; it is also about the networks of support that surround that individual—not only health professionals, but mums, dads, grandparents, siblings, friends, teachers, colleagues and many others.

• 26 Feb 2026 · Eating Disorders Awareness Week · Hansard source

  More

  I wholeheartedly agree. The Government are committed to ending the revolving door for many conditions—this is an exemplar, in many ways—by joining up care and the streams of information that underpin it. One of our main commitments in our 10-year health plan is to have more joined-up care, to move it from sickness to prevention and to move from hospital into community, where that join-up can happen. This community can thrive only when it is built on a foundation of timely, effective care. That is why we are focused on reforming eating disorder services so that people can access help when they need it, not after their condition has escalated. That approach underpins the new NHS guidance for children and young people’s eating disorder services, published last month, which is clear that care should be timely, joined up and delivered as close to home as possible. As many here know, demand for mental health support, including eating disorder services, rose sharply during the pandemic, and the rise has been sustained thereafter. Although services remain under significant pressure, as a result of the additional investment there are some green shoots in system capacity and capability to better meet rising demand and reduce the waits that hon. Members have described. In December 2025, 83.3% of routine referrals to children and young people’s community eating disorder services and 78.8% of urgent referrals started treatment within four weeks and one week respectively. That is a marked improvement in performance, compared with the situation six months earlier. In June last year, only 72.2% of routine referrals and 63.7% of urgent referrals were seen within four weeks and one week respectively. Although those are encouraging signs, I am under no illusion: too many children and young people are still waiting far too long for support. That is exactly why further reform and delivery are needed. The Government’s long-term approach to mental health reform is set out in the 10-year health plan, which is clear in its direction. It shifts care from hospital to community, from sickness to prevention and, of course, from analogue to digital, which will be so important when it comes to having joined-up care. I assure hon. Members that those shifts are not abstract principles, but practical changes that are already being embedded. I know that they matter deeply for people living with eating disorders, and the families and loved ones who support them. But I recognise that plans alone do not deliver care. Delivery depends on people and having the right workforce with the right skills in the right places. That is why, on top of the workforce plan that will come to fruition in late spring or early summer, we are investing in the workforce. We are committed to providing an additional 8,500 new mental health professionals across child and adult mental health services, to cutting waiting times and to ensuring that people access treatment and support earlier than ever before. We are also working to strengthen skills and capability across the system. NHS England has introduced comprehensive training to ensure that staff across mental and physical health services can recognise eating disorders early and respond safely and effectively. That training supports clinicians working not only in the community but in primary and, crucially, acute care settings, where I used to work. I often saw such patients on my acute general surgical receiving ward rounds. The training includes specialist programmes, including the Royal College of Psychiatrists’ eating disorders credential, expanded access to family-based therapies, cognitive behavioural therapy for eating disorders, and dedicated training on ARFID, which the hon. Member for Sleaford and North Hykeham (Dr Johnson) mentioned. That work is about giving staff the skills, confidence and, crucially, clarity they need to deliver safe, high-quality care and reduce some of the avoidable harm that we have discussed today. I am pleased to say that funding for children and young people’s eating disorder services has increased significantly, from £46.7 million in 2017-18 to an actual spend of £106.3 million in 2024-25. With that extra funding, we have focused on enhancing the capacity of community eating disorder teams across the country, because we know that timely, effective care leads to better outcomes, supports recovery and helps to prevent conditions escalating to the point at which hospital admission becomes inevitable. When admission is necessary, stronger community care can reduce length of stay when it is safe. We recognise the concerns that in-patient capacity remains under pressure in some parts of our country. There are reports of individuals being discharged at very low body mass due to bed availability, as the hon. Member for Bath highlighted. Discharge decisions must always be about clinical judgment and patient safety, not capacity constraints. NHS England reassures me and continues to work with providers and integrated care boards to ensure that sufficient specialist provision and safe step-down pathways will be in place.

• 24 Feb 2026 · Access to Mental Health Services · Hansard source

  More

  Mental health issues affect all ages, and the support is not always there. We are determined to change that. We have hired almost 8,000 extra mental health workers since we came into office and increased investment in mental health by an additional £688 million this year. We are also transforming services through community-based 24/7 mental health centres, providing open access to treatment and support for adults with severe mental health needs, expanding NHS talking therapies, and rolling out mental health support teams in more schools.

• 12 Feb 2026 · Pharmacy First: Withholding Payments · Hansard source

  More

  The hon. Member is right that under the Pharmacy First programme, contractors receive a monthly fixed payment upon delivering a minimum number of consultations, as per the 2025-26 agreement. That can go up and down month to month, in a dynamic process, depending on how many patients are seen in pharmacies. I completely take his point that we are evolving our care system, and ensuring a move from hospital to community, but are not quite there yet; however, I think we are on the road. Through our neighbourhood health programme, we are solidifying the relationships between general practice, pharmacies, opticians and other allied health professionals in primary care.

• 12 Feb 2026 · Pharmacy First: Withholding Payments · Hansard source

  More

  As the hon. Gentleman will know—or should know—the current remuneration method was agreed in conjunction with the sector. The adjustment was agreed with the sector’s representative body, Community Pharmacy England. Advance notice of the change was provided to those contractors by letter and in an article published by the NHS Business Services Authority in May 2025. In addition, Community Pharmacy England knows that, should this be a priority issue for it to negotiate in the next contract, we will take that on board and use it as an option. There are of course always extenuating circumstances, such as IT not working. Officials have reassured me that, following discussions with Community Pharmacy England, we have introduced specific provisions in the drug tariff that will allow pharmacy contractors to receive payment for claims that were delayed due to IT issues outside of its control. I can appreciate why the hon. Gentleman wants to expand the remit of the urgent question across primary care—well, let me tell him. I know he had neck surgery recently; I did not realise they put a brass neck in him as well when they did it. He knows what kind of NHS decline and decay over which he and his Government presided over the past 15 years: primary care where people are left wandering around asking for GPs, and the Conservatives left GPs on the scrapheap, unemployed. This Government ensured, when they came into office, that—

• 12 Feb 2026 · Pharmacy First: Withholding Payments · Hansard source

  More

  It is a pleasure to take the traditional Department of Health and Social Care urgent question before recess—I would not miss it for the world. Since coming into office, we have reversed the decade of cuts to community pharmacy with the biggest uplift for the sector in years and frozen prescription charges to help our constituents with the cost of living, and women can now get the morning-after pill free of charge across the country. Earlier this week, I spoke to the National Pharmacy Association’s winter reception to pay tribute to its members for their work and to assure them that I have their back, as does the Minister for Care. The hon. Member for Hinckley and Bosworth (Dr Evans) raises the important issue of payments made via Pharmacy First. As he knows, pharmacy contractors receive a monthly fixed payment if they meet certain requirements. We agreed to reduce the claim window, in conjunction with Community Pharmacy England, as part of our deal for 2025-26 to introduce a new Pharmacy First fixed first payment of £500. That has supported a broader range of pharmacies and has meant that more pharmacies have become eligible for payments. We are in discussions with Community Pharmacy England to consider where improvements to the claiming process can be made, address concerns raised by contractors and aim for a more consistent approach to remuneration. We will also consult with Community Pharmacy England shortly on the contractual framework for next year. There are issues relating to contractors being suspended from providing Pharmacy First that are for separate consideration. When concerns are raised, NHS England can suspend individual contractors from providing the service pending a full investigation. There are a number of reasons why that might be necessary, but the measures are there, first and foremost, as the House will appreciate, to protect patient safety. I am a clinician, as is the hon. Member for Hinckley and Bosworth, and I am sure that he will agree that patient safety should be at the forefront of everything we do. Finally, funding for the core community pharmacy contractual framework has been increased to over £3 billion—the largest uplift of any part of the NHS in the last two years. As part of this year’s contractual framework, we have agreed to keep the current cost control mechanism linked to Pharmacy First that we inherited from the previous Government to ensure that the money is spent within that envelope. I thank the hon. Gentleman for his question.

• 9 Feb 2026 · Brain Tumour Survival Rates · Hansard source

  More

  I start by thanking my hon. Friend the Member for Mitcham and Morden (Dame Siobhain McDonagh), and the hon. Members for Witney (Charlie Maynard) and for Kingswinford and South Staffordshire (Mike Wood) for supporting this important debate. I would like to take a few moments to acknowledge the contributions of all hon. Members across this House—from personal experience, I know how hard it is to talk about these issues when people close to your family are lost to brain tumours. They include my aunt, who was instrumental in my pursuing a career in medicine. She passed away in 1997, only four months after a diagnosis of glioblastoma. The hon. Member for Witney asked about consent in relation to tumour tissue research, which is a really important and pertinent topic. I am very happy to go away and consult with the Human Tissue Authority regarding the facility we have at the moment, which is quite sizeable, for securing consent to research on tissue from living persons and deceased persons. As a transplant surgeon, I am relatively au fait with some of the consent issues that can arise in using tissue from deceased persons, and I am always very happy to encourage consideration of those issues wherever possible. The hon. Member rightly challenged us to improve our architecture for digital consent. We continue to do so through our “analogue to digital” platform, on which the 10-year health plan is based, not only for care but for research. I thank my hon. Friend the Member for Colne Valley (Paul Davies) and the hon. Member for Mid Dunbartonshire (Susan Murray) for their thought-provoking contributions to this debate, as well as my hon. Friend the Member for Edinburgh South West (Dr Arthur), who talked so passionately about these issues. I thank him once again for bringing forward his private Member’s Bill, which will do so much to move the dial on research, not only on brain tumours but on rare cancers more generally. He had a specific ask about visa costs for talent coming from elsewhere in the world, and I assure him that we are looking seriously into these issues. Only today, I was chairing a session of the Life Sciences Council, where we talked about the global talent fund. That is pertinent to the discussions that my hon. Friend is having, and I am happy to put the council in touch with him to further those discussions regarding how we attract the brightest and the best to our country to advance the cause of life sciences generally, as well as the cause of researching rare cancers. The hon. Member for Wokingham (Clive Jones) talked more specifically about referral targets. I can reassure him that we are totally committed as a Government to hitting those national standards on 62-day waits. He challenged us to go to 100%. I caution him that although 85% is possible, 100% is not, usually for clinical reasons. There may be genuine clinical reasons why patients cannot access treatment within 62 days in terms of planning and specialist access. My right hon. Friend the Member for Hayes and Harlington (John McDonnell) talked about diagnostics. That issue is close to my heart, and I reassure him that through the continued opening of community diagnostic centres up and down the country and £2 billion of funding, I am determined to ensure that diagnostics is improved and available closer to home wherever possible. The hon. Member for North East Hampshire (Alex Brewer) talked about her friend being diagnosed with a brain tumour in A&E. As someone who was a young casualty officer many years ago, that resonated strongly with me. The A&E department is the last place where any tumour should be diagnosed, but I remember it happening far too frequently as a young casualty officer. One litmus test of the success of our cancer plan will be that much fewer of those diagnoses will be undertaken in an unplanned fashion in A&Es up and down our country. I am always grateful for the learned remarks of my hon. Friend the Member for Bury St Edmunds and Stowmarket (Peter Prinsley). I always feel like I learn so much from him. In fact, I learned so much tonight that I might add his contribution to my portfolio of continuing professional development when I submit myself back to the General Medical Council to extend my licence. The hon. Member for Strangford (Jim Shannon) always raises thought-provoking issues about four-nation working. I assure him that I continually and frequently discuss many matters pertaining to the health of our four nations with the Minister of Health in Northern Ireland. I can also reassure him of our UK-wide commitment to the life sciences sector plan and life sciences project. On that note, it was my great pleasure to meet academics from Queen’s University Belfast in this place only a few months ago, where I reaffirmed my commitment as life sciences Minister to the life sciences sector plan being a true four-nation project. That of course includes Northern Ireland, and I know from my own academic interests that much expertise resides in Northern Ireland. The hon. Member for Epsom and Ewell (Helen Maguire) talked about benign tumours not being forgotten, and she is absolutely right. Those of us from a medical background know that it is a spectrum between benign and malignant tumours. Many benign tumours can evolve into malignant tumours, and they must be captured by plans such as the national cancer plan. She challenged me about publishing regular outcomes from the national cancer plan, and I can certainly commit to that. Those can be scrutinised in the normal way by the Health and Social Care Committee. The shadow Minister, the hon. Member for Sleaford and North Hykeham (Dr Johnson) talked about screening. She will know, as I do, that screening is important when it is evidence-based and where the benefits outweigh the harms. Screening is never harm-free, so it is important to ensure we are calculating these things based on expert evidence. Neither she nor I are experts in screening, so we always defer to the UK National Screening Committee and its deliberations and opinions on these matters. The shadow Minister asked me about the workforce plan. I can assure her that that is in play and will be published shortly, in the spring or very early summer. She asked how that might interact with diagnostic capacity, and I can assure her that we are working at great speed to ramp up diagnostic capacity through the funding envelope that I mentioned. She will know that it is important, when we plan both for workforce and diagnostic capacity, to take account of AI moving at a rapid pace. We have already been able to eliminate one radiologist from breast cancer diagnoses, and it is entirely possible that we will be able to have a similar impact with technology on the rates of other cancers and, for example, lung cancer diagnostics. It is important that, as we work through the workforce plan, we take account of what the future will look like in that context. When we came to the topic of the potential association between traumatic brain injury and brain tumours and my hon. Friend the Member for Bury St Edmunds and Stowmarket intervened on the hon. Member for Sleaford and North Hykeham, the medical man in me could not help himself. I looked at PubMed quickly to check whether there was indeed an association, and I picked out a paper that may be of interest to the medical people in this place. Following 24 years’ worth of data from Mass General Brigham hospital, with 75,000 patients on each arm looked at retrospectively, there would seem to be a mild association between severe traumatic brain injury and the diagnosis of malignant brain tumours.

• 20 Jan 2026 · ADHD Diagnosis · Hansard source

  More

  At present, the hon. Gentleman will have to ask my colleague the mental health Minister about the specifics, but my understanding is that the prevalence review will be a wider piece of work that will be partly informed by the ADHD taskforce report. It would be better to respond to them as a combination rather than as individual reports. The House will know that on 4 December 2025 the Secretary of State announced the launch of the independent review into prevalence and support for mental health conditions, ADHD and autism. It will bring together the most respected researchers, clinicians and voluntary organisations in the country, alongside, crucially, people with lived experience, who will be directly engaged to scrutinise the evidence and support the development of recommendations. Part of that will be about how we address and label reporting, and I would expect that we come up with a better definition and a better way of reporting than we have at the moment. The Government’s 10-year plan sets out the core principle of early intervention and support, and will make the NHS fit for the future. Through the NHS medium-term planning framework, published in October 2025, NHS England has set an expectation that local ICBs and trusts improve access, experience and outcomes for ADHD services over the next three years. I heard the call from hon. Members for much more integration between community mental health services, GPs and other healthcare bodies. It is our expectation that through the NHS reform Bill and the disbanding of NHS England, as well the production of independent health authorities and strategic commissioning, the health service will be better able to serve the needs of children requiring assessment for mental health conditions and ADHD. We will end up having a helicopter view, which is currently not possible.

• 3 Dec 2025 · Terminal Illness: Mental Health Support · Hansard source

  More

  The mental health investment standard is something that we expect ICBs to meet. I will gently push back on what the hon. Gentleman is saying because, as we have been so succinctly reminded in this debate, investing in mental wellbeing is about more than just headline figures. For instance, we need psychology in oncology, in children’s health, and in other forms of cancer care. The provision of such services is not always recorded in the way that the hon. Gentleman would wish it to be recorded, but there are still formats and sub-types of mental health support. The Government are also keen to press ahead with our 10-year plan, and we are setting out ambitious plans to boost mental health support across the country while delivering the shift from hospital to community. As part of that process, we wish to open around 85 mental health emergency departments, reducing pressure on busy A&E services, which are the last places that people with mental health needs should be, and ensuring that people have the right support they need in a calm, compassionate environment. We will also use new integrated health organisations to break down barriers between services, which I also think is really important in the context of this debate, and to ensure integrated and holistic care, addressing both physical and mental healthcare needs, with more freedom to determine how best to meet the needs of those local populations. That will build on the work that has already begun to bring down waiting lists. As I said, we are investing an extra £688 million this year to transform mental health services. On staffing, I am pleased to say that almost 7,000 extra mental health workers have been recruited since July 2024, against our target of 8,500 by the end of this Parliament. We are also expanding talking therapies, and we have committed to continuing that expansion over the coming years. More adults already benefit from better access to those therapies, and the aim is for over 900,000 people to complete a course of treatment with improved effectiveness and quality of services by March 2029. Anyone who develops a common mental health condition, such as anxiety or depression, in any context, including terminal illness, can self-refer to talking therapies. [ Interruption. ]